Efficacy and safety of sitagliptin added to ongoing metformin and pioglitazone combination therapy in a randomized, placebo-controlled, 26-week trial in patients with type 2 diabetes
Titel:
Efficacy and safety of sitagliptin added to ongoing metformin and pioglitazone combination therapy in a randomized, placebo-controlled, 26-week trial in patients with type 2 diabetes
Auteur:
Fonseca, Vivian Staels, Bart Morgan II, Jerry D. Shentu, Yue Golm, Gregory T. Johnson-Levonas, Amy O. Kaufman, Keith D. Goldstein, Barry J. Steinberg, Helmut